Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function

Lignende værker

• The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor
  af: Chan, Yi-Hsin, et al.
  Udgivet: (2021)
• The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
  af: Ling, Ann Wan-Chin, et al.
  Udgivet: (2020)
• The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
  af: Lan, Nick S.R., et al.
  Udgivet: (2019)
• Analysis of left ventricular systolic function
  af: Schiller, Nelson B, et al.
  Udgivet: (1996)
• Effect of sodium-glucose cotransporter 2 inhibitors on ventricular function in systemic right ventricular failure
  af: Lorna Swan, et al.
  Udgivet: (2025-10-01)